IMI’s EBiSC project has established a centralised, not-for-profit human induced pluripotent stem cell (iPSC) bank providing researchers across academia and industry with access to scalable, cost-efficient and consistent, high quality iPSCs for use in research and medicines development. Since its creation in 2014, the bank has grown considerably and now provides a large range of iPSC lines and services to academics, non-profit organisations and companies. Projects generating iPSCs can also make their cell lines sustainable by depositing them in the EBiSC catalogue, ensuring secure long-term storage and simplified access and distribution.
The new EBiSC2 project builds on the achievements of the original EBiSC project, including improving its services and providing new iPSC lines and differentiated cell products.
66280 Sulzbach / Saar
Login to display
|Working on iPSCs for research or medicines development? Introducing EBiSC services and cel...||15 Oct 2019||1571134060|
|A new cohort of iPSC lines available from EBiSC will accelerate research into Huntingtonâ€...||10 Feb 2020||1581339618|